
Get exclusive money-saving offers and guides
Straight to your inbox
Updated
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Imricor Medical Systems, Inc is a medical devices business based in Australia. Imricor Medical Systems, Inc shares (IMR) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Imricor Medical Systems, Inc has a trailing 12-month revenue of around $862,693..
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
52-week range | $0.75 - $2.8 |
---|---|
50-day moving average | $2.3129 |
200-day moving average | $1.6406 |
Target price | N/A |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.186 |
Standard brokerage - Australian shares
Competitive broker fees on Australian and international shares
Important: Share trading carries risk of capital loss.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of A$2.5 on 2020-10-22
1 week (2021-01-11) | 3.31% |
---|---|
1 month (2020-12-21) | 11.11% |
3 months (2020-10-21) | -1.96% |
6 months (2020-07-21) | 44.51% |
1 year (2020-01-17) | 113.68% |
---|---|
2 years (2019-01-17) | N/A |
3 years (2018-01-17) | N/A |
5 years (2016-01-17) | N/A |
Revenue TTM | $862,693 |
---|---|
Gross profit TTM | $262,339 |
Return on assets TTM | -43.01% |
Return on equity TTM | -696.62% |
Profit margin | 0% |
Book value | 0.13 |
Market capitalisation | $286.1 million |
TTM: trailing 12 months
We're not expecting Imricor Medical Systems, Inc to pay a dividend over the next 12 months.
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States and Europe. The company's principal products include the Advantage-MR EP Recorder/Stimulator system, an electrophysiology amplifier and recording system with integrated cardiac stimulator; Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode, an ablation dispersive electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. The company also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was founded in 2006 and is headquartered in Burnsville, Minnesota.
Steps to owning and managing Vanguard Australian Fixed Interest Index ETF units.
Steps to owning and managing Vanguard Ethically Conscious Global Aggregate Bond Index (Hedged) ETF units.
Steps to owning and managing ETFS Morningstar Global Technology ETF units.
Steps to owning and managing BetaShares Global Quality Leaders (Currency Hedged) ETF units.
Steps to owning and managing ETFS ROBO Global Robotics and Automation ETF units.
Steps to owning and managing ETFS FANG+ ETF units.
Steps to owning and managing ETFS S&P Biotech ETF units.
Steps to owning and managing ETFS Reliance India Nifty 50 ETF units.
Steps to owning and managing BetaShares India Quality ETF units.